Avni Akin Bayram
Avni Akin Bayram has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Cem Çelik
Department of Otorhinolaryngology, Gaziantep City Hospital, Gaziantep, Türkiye
2 shared publications - Ali Ozan Yazıcı
Department of Otorhinolaryngology, University of Health Sciences, Professer Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey
1 shared publication - Ayça Başkadem Yılmazer
Department of Otorhinolaryngology, Sağlık Bilimleri University, Prof. Dr. Cemil Taşçıoğlu Hospital, İstanbul, Türkiye
1 shared publication - Ayşe Enise Göker
Prof Dr Cemil Tascıoglu Hospital, Department of Otorhinolaryngology University of Saglik Bilimleri Istanbul Turkey
1 shared publication - Elif Aksungur
Prof Dr Cemil Tascıoglu Hospital, Department of Otorhinolaryngology University of Saglik Bilimleri Istanbul Turkey
1 shared publication - Gamze Allahverdi
Department of Otorhinolaryngology, University of Health Sciences, Professer Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 7 October 2026
- Published by Springer Nature in The Egyptian Journal of Otolaryngology
- Vol. 42 (1) , 259
Nerve-oriented extracapsular dissection versus superficial parotidectomy in selected benign parotid tumours: a retrospective cohort study with propensity score–matched analysis
Background: Extracapsular dissection (ECD) is proposed as a less invasive alternative to superficial parotidectomy (SP) for clinically benign parotid tumours. Because the choice of technique is driven by tumour characteristics, it is uncertain how far reported differences reflect the operation rather than the indication. We reviewed 146 consecutive patients operated on for benign parotid tumours between 2015 and 2023 (SP 104, ECD 42), recording complications, recurrence and aesthetic satisfaction on a visual analogue scale (VAS), with facial nerve function graded by House–Brackmann. Groups were compared without adjustment, by multivariable logistic regression and by 1:1 propensity score matching; post hoc exploratory analyses stratified by histology and by operating surgeon were added after peer review. Results: Recurrence occurred in 16/104 (15.4%) after SP and 1/42 (2.4%) after ECD ( p = 0.025); transient facial nerve dysfunction showed the same figures ( p = 0.025), with no permanent dysfunction. Fistula, Frey syndrome and sialocele were less frequent after ECD without reaching significance, and VAS did not differ ( p = 0.173). Tumour size was associated with higher odds of Frey syndrome (OR 2.95; p = 0.028). Matching produced 38 pairs with residual imbalance in five covariates; recurrence (1/38 vs. 6/38; p = 0.25) and facial nerve dysfunction (1/38 vs. 4/38; p = 0.75) did not differ. In post hoc analyses the recurrence difference was confined to Warthin tumour (0/15 vs. 10/43; p = 0.050) and absent in pleomorphic adenoma (1/22 vs. 6/56; p = 0.67). One surgeon performed all 42 ECD and 45 SP procedures; within his own cases no difference between the techniques was detected (1/42 vs. 3/45; p = 0.62), whereas recurrence varied substantially between surgeons (4/87, 4.6% vs. 13/59, 22.0%; p = 0.003). Conclusion: No statistically significant difference between the techniques was detected after adjustment or matching. The crude recurrence difference was confined to the Warthin subgroup, while the ECD arm was completely confounded with operating surgeon and with the selection of favourable tumours. These data establish neither superiority nor equivalence of either technique, and indicate that the extent of parotid surgery should be tailored to the individual lesion.
- 7 October 2026
- Published by Springer Nature in The Egyptian Journal of Otolaryngology
- Vol. 42 (1) , 259
Open AccessNerve-oriented extracapsular dissection versus superficial parotidectomy in selected benign parotid tumours: a retrospective cohort study with propensity score–matched analysis
Background: Extracapsular dissection (ECD) is proposed as a less invasive alternative to superficial parotidectomy (SP) for clinically benign parotid tumours. Because the choice of technique is driven by tumour characteristics, it is uncertain how far reported differences reflect the operation rather than the indication. We reviewed 146 consecutive patients operated on for benign parotid tumours between 2015 and 2023 (SP 104, ECD 42), recording complications, recurrence and aesthetic satisfaction on a visual analogue scale (VAS), with facial nerve function graded by House–Brackmann. Groups were compared without adjustment, by multivariable logistic regression and by 1:1 propensity score matching; post hoc exploratory analyses stratified by histology and by operating surgeon were added after peer review. Results: Recurrence occurred in 16/104 (15.4%) after SP and 1/42 (2.4%) after ECD ( p = 0.025); transient facial nerve dysfunction showed the same figures ( p = 0.025), with no permanent dysfunction. Fistula, Frey syndrome and sialocele were less frequent after ECD without reaching significance, and VAS did not differ ( p = 0.173). Tumour size was associated with higher odds of Frey syndrome (OR 2.95; p = 0.028). Matching produced 38 pairs with residual imbalance in five covariates; recurrence (1/38 vs. 6/38; p = 0.25) and facial nerve dysfunction (1/38 vs. 4/38; p = 0.75) did not differ. In post hoc analyses the recurrence difference was confined to Warthin tumour (0/15 vs. 10/43; p = 0.050) and absent in pleomorphic adenoma (1/22 vs. 6/56; p = 0.67). One surgeon performed all 42 ECD and 45 SP procedures; within his own cases no difference between the techniques was detected (1/42 vs. 3/45; p = 0.62), whereas recurrence varied substantially between surgeons (4/87, 4.6% vs. 13/59, 22.0%; p = 0.003). Conclusion: No statistically significant difference between the techniques was detected after adjustment or matching. The crude recurrence difference was confined to the Warthin subgroup, while the ECD arm was completely confounded with operating surgeon and with the selection of favourable tumours. These data establish neither superiority nor equivalence of either technique, and indicate that the extent of parotid surgery should be tailored to the individual lesion.
- Open Access
- 19 October 2024
- Published by Wiley in Clinical Otolaryngology
- Vol. 50 (1) , 122-127
Results of Platelet‐Rich Fibrin Application in Pharyngeal Reconstruction After a Total Laryngectomy
Introduction: Pharyngocutaneous fistula (PCF) is one of the most challenging complications observed after a total laryngectomy. Since the biochemical components of platelet‐rich fibrin (PRF) have well‐known synergistic effects on the healing processes, this study aimed to demonstrate the contribution of PRF application to pharyngeal healing in patients undergoing a total laryngectomy for laryngeal cancer.Methods: The study compared patients who underwent a total laryngectomy due to laryngeal squamous cell carcinoma and had a PRF membrane placed during the pharyngoesophageal closure with those who did not. There were two groups: PRF‐positive and PRF‐negative. In the PRF‐positive group, after the completion of the total laryngectomy and moving on to the pharyngoesophageal closure stage, along the suture line, PRF material is laid in two pieces in a T‐shape and secured with several sutures. No PRF application was done in the PRF‐negative group. Pharyngeal healing steps (nasogastric feeding, oral feeding, development of a fistula), haemoglobin and albumin values, tumour involvement areas, time to oral intake and length of hospital stay were recorded for all patients.Results: This study reviewed the records of 33 patients who underwent pharyngoesophageal closure with PRF application after a total laryngectomy (PRF‐positive group) and 35 patients without PRF application (PRF‐negative group). When comparing patients in terms of developing a PCF, 6% (n = 2) of patients in the PRF‐positive group and 25.7% (n = 9) in the PRF‐negative group developed a fistula. This ratio was significantly higher in the PRF‐negative group (p = 0.027).Conclusion: The application of PRF in pharyngoesophageal reconstruction after a total laryngectomy may strengthen wound healing and reduce the risk of PCF development.Trial Registration: This study is a retrospective designed study; therefore, there is no clinical trial registration
- 19 October 2024
- Published by Wiley in Clinical Otolaryngology
- Vol. 50 (1) , 122-127
Open AccessResults of Platelet‐Rich Fibrin Application in Pharyngeal Reconstruction After a Total Laryngectomy
Introduction: Pharyngocutaneous fistula (PCF) is one of the most challenging complications observed after a total laryngectomy. Since the biochemical components of platelet‐rich fibrin (PRF) have well‐known synergistic effects on the healing processes, this study aimed to demonstrate the contribution of PRF application to pharyngeal healing in patients undergoing a total laryngectomy for laryngeal cancer.Methods: The study compared patients who underwent a total laryngectomy due to laryngeal squamous cell carcinoma and had a PRF membrane placed during the pharyngoesophageal closure with those who did not. There were two groups: PRF‐positive and PRF‐negative. In the PRF‐positive group, after the completion of the total laryngectomy and moving on to the pharyngoesophageal closure stage, along the suture line, PRF material is laid in two pieces in a T‐shape and secured with several sutures. No PRF application was done in the PRF‐negative group. Pharyngeal healing steps (nasogastric feeding, oral feeding, development of a fistula), haemoglobin and albumin values, tumour involvement areas, time to oral intake and length of hospital stay were recorded for all patients.Results: This study reviewed the records of 33 patients who underwent pharyngoesophageal closure with PRF application after a total laryngectomy (PRF‐positive group) and 35 patients without PRF application (PRF‐negative group). When comparing patients in terms of developing a PCF, 6% (n = 2) of patients in the PRF‐positive group and 25.7% (n = 9) in the PRF‐negative group developed a fistula. This ratio was significantly higher in the PRF‐negative group (p = 0.027).Conclusion: The application of PRF in pharyngoesophageal reconstruction after a total laryngectomy may strengthen wound healing and reduce the risk of PCF development.Trial Registration: This study is a retrospective designed study; therefore, there is no clinical trial registration